NDC codes

415464 NDC codes with hospital pricing data in the network.

• NDC 51079-0801-20 — Metoprolol tartrate 50 mg tabletsAI (739 hospitals, 29,374–30,076 samples)
• NDC 70860-0300-05 — metoprolol tartrate 5 mg/5 mL intravenous solutionAI (305 hospitals, 29,100–30,063 samples)
• NDC 00517-6710-10 — Calcium chloride 10% IV solutionAI (520 hospitals, 29,799–30,060 samples)
• NDC 63323-0489-21 — Lidocaine with epinephrine injection, 20 mL vialAI (265 hospitals, 28,186–30,058 samples)
• NDC 51672-4001-01 — Nortriptyline 10 mg capsules, bottle of 100AI (522 hospitals, 29,415–30,036 samples)
• NDC 60687-0836-01 — Carbidopa and levodopa 25/250 mg tabletsAI (417 hospitals, 29,401–30,031 samples)
• NDC 51079-0051-20 — Pantoprazole 40 mg delayed-release tabletAI (468 hospitals, 28,901–30,017 samples)
• NDC 47781-0587-17 — Metoprolol tartrate 5 mg/5 mL IV solutionAI (157 hospitals, 29,167–30,013 samples)
• NDC 00143-9391-01 — remifentanil 1 mg intravenous solutionAI (284 hospitals, 28,943–29,987 samples)
• NDC 00172-2083-60 — hydroCHLOROthiazide 25 mg tabletAI (402 hospitals, 29,327–29,984 samples)
• NDC 00904-6927-61 — Spironolactone 25 mg tabletsAI (554 hospitals, 29,326–29,983 samples)
• NDC 00781-7133-54 — Estradiol weekly transdermal patch, 0.05 mg/24 hrAI (164 hospitals, 29,009–29,981 samples)
• NDC 81298-7620-03 — Sodium bicarbonate 8.4% intravenous solutionAI (174 hospitals, 29,054–29,981 samples)
• NDC 44567-0603-24 — Dexmedetomidine in dextrose 5% solution, 4 mcg/mL bagAI (267 hospitals, 29,546–29,978 samples)
• NDC 00904-7008-61 — Lamotrigine 100 mg tabletAI (645 hospitals, 29,202–29,976 samples)
• NDC 63323-0093-30 — Concentrated sodium chloride solution vialAI (786 hospitals, 29,687–29,957 samples)
• NDC 00338-3814-50 — Clindamycin 900 mg IV solution in dextroseAI (560 hospitals, 27,958–29,956 samples)
• NDC 00008-0923-51 — Pantoprazole 40 mg IV injectionAI (618 hospitals, 26,852–29,948 samples)
• NDC 60687-0664-01 — Hydroxyzine 10 mg tabletsAI (445 hospitals, 29,103–29,940 samples)
• NDC 42023-0186-01 — Dexmedetomidine injection premixed in salineAI (66 hospitals, 29,692–29,935 samples)
• NDC 08290-3065-47 — Sodium chloride 0.9% saline IV solutionAI (235 hospitals, 19,442–29,927 samples)
• NDC 71266-6290-01 — Lidocaine, epinephrine and tetracaine topical gelAI (454 hospitals, 28,892–29,909 samples)
• NDC 60687-0580-01 — Gabapentin 100 mg capsulesAI (539 hospitals, 28,962–29,889 samples)
• NDC 00904-6640-61 — Quetiapine 100 mg tabletsAI (680 hospitals, 29,179–29,881 samples)
• NDC 51672-4025-04 — amiodarone 200 mg tabletAI (345 hospitals, 29,218–29,875 samples)
• NDC 00003-0293-05 — Kenalog-40 triamcinolone injection suspensionAI (895 hospitals, 24,897–29,874 samples)
• NDC 68084-0808-01 — Tramadol 50 mg tabletsAI (399 hospitals, 28,760–29,858 samples)
• NDC 00406-9125-76 — Fentanyl 25 mcg/hr skin patchAI (447 hospitals, 29,047–29,857 samples)
• NDC 70860-0600-41 — Midazolam 1 mg/mL injectionAI (221 hospitals, 25,436–29,846 samples)
• NDC 55150-0160-72 — Lidocaine 2% solution (preservative-free)AI (136 hospitals, 29,744–29,843 samples)
• NDC 65628-0050-04 — Magic mouthwash liquid, single unit doseAI (311 hospitals, 28,995–29,841 samples)
• NDC 00065-0397-15 — CYCLOPENTOLATE 2 % EYE DROPSAI (91 hospitals, 29,023–29,833 samples)
• NDC 00548-9502-00 — Isoproterenol injection, 0.2 mg/mLAI (373 hospitals, 28,869–29,823 samples)
• NDC 60687-0155-01 — Metformin 500 mg tablets, 100-count blister packAI (568 hospitals, 28,737–29,817 samples)
• NDC 00378-7970-93 — Ipratropium bromide inhalation solutionAI (201 hospitals, 28,951–29,815 samples)
• NDC 00487-9801-25 — Ipratropium bromide inhalation solutionAI (189 hospitals, 28,950–29,805 samples)
• NDC 69097-0861-07 — zonisamide 100 mg capsuleAI (260 hospitals, 29,192–29,804 samples)
• NDC 00409-5534-34 — Sodium bicarbonate IV syringeAI (306 hospitals, 28,814–29,795 samples)
• NDC 68547-0501-02 — Angiotensin II injection vialAI (553 hospitals, 25,285–29,776 samples)
• NDC 17478-0937-10 — DILTIAZEM 5 MG/ML INTRAVENOUS SOLUTIONAI (213 hospitals, 29,215–29,764 samples)
• NDC 08065-1831-35 — Chondroitin-sodium hyaluronate eye injection syringeAI (183 hospitals, 28,822–29,749 samples)
• NDC 50268-0087-12 — Aripiprazole 2 mg tabletsAI (377 hospitals, 28,995–29,742 samples)
• NDC 00378-0222-01 — CHLORTHALIDONE 25 MG TABLETAI (298 hospitals, 29,044–29,737 samples)
• NDC 60687-0591-01 — Gabapentin 300 mg capsulesAI (581 hospitals, 28,647–29,727 samples)
• NDC 60267-0311-10 — Sodium nitrite injection, 10 mL vialAI (317 hospitals, 28,874–29,720 samples)
• NDC 00904-6300-61 — Carvedilol 3.125 mg tabletsAI (511 hospitals, 29,110–29,713 samples)
• NDC 70092-1546-35 — Hydromorphone (preservative-free) in saline bag, 50 mLAI (194 hospitals, 28,840–29,704 samples)
• NDC 00068-0597-01 — rifAMPin 600 mg intravenous solutionAI (749 hospitals, 27,555–29,697 samples)
• NDC 60687-0325-01 — Lisinopril 10 mg tabletsAI (474 hospitals, 28,666–29,683 samples)
• NDC 63323-0088-63 — Sodium chloride intravenous solutionAI (117 hospitals, 29,554–29,680 samples)